|Bid||1.9100 x 2900|
|Ask||1.9400 x 21500|
|Day's Range||1.8900 - 1.9600|
|52 Week Range||1.0400 - 3.8200|
|Beta (5Y Monthly)||1.79|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for AMRN
Sarissa Capital is pushing to get a slate of directors on the board of pharmaceutical firm Amarin. Hudson Executive disclosed a large stake in radiation-treatment equipment maker ViewRay.
Shares of Amarin Corporation (AMRN) fell last week as the company's largest shareholder pressurizes the company to make changes to its board of directors.
Amarin's tussle with its largest stakeholder doesn't appear to be sitting well with shareholders.